Recently Otto et aZ.(1) published a report on some of the clinical aspects of tryptaminestrophanthidin, a new compound which has a typical digitalis action on the isolated cat papillary muscle and on patients with auricular fibrillation. Tryptamine-strophanthidin differs from the usual synthetic drugs of the strophanthidin series in that it has the tryptamine residue condensed with the aldehyde group in position 10 of the cyclopentanoperhydrophenanthrene nucleus rather than to the hydroxyl group in position 3. Because the available information indicated a high potency for this new drug, we decided to conipare its action with that of strophanthin-K after intraventricular injection in unanesthetized dogs.
Methods. Fifteen, normal mongrel dogs of both sexes, weighing 7.8 to 16.1 kg, were anesthetized with sodium pentobarbital, 3 5 mg/ kg, intravenously, and an indwelling third ventricle cannula inserted as described previously ( 4) . The animals were used one week later in the unanesthetized state. All third ventricle injections were made via a polyethylene tube attached to the cannula. The total volume injected per dose varied from 0.2 to 1 ml. Five additional dogs were used for intravenous controls and received their injections via the anterior subcutaneous vein of the foreleg. Electrocardiograms were obtained with a Sanborn Viso-Cardiette using Lead 11. Table I gives a comparison of typical effects produced by the 2 drugs. Intraventricular injection of 6.4 pg/kg of strophan thin-K produced bigeminy and bradycardia while 8.4 pg/kg resulted in an auricular tachycardia. Secondary effects consisted of : mydriasis, salivation, defecation, shivering, mucous membrane and retinal pallor, and a generalized tremor. Doses of 31.4 to 57.4 pg/kg of strophanthin-K produced ventricular extrasystoles and paroxysmal ventricular tachycardia within 3 minutes. In some animals, sinus tachycardia, periodic P-wave supression, bigeminy, trigeminy, and multi-f ocal ventricular tachycardia were observed after 2 to 9 minutes. Additional secondary effects were: lateral or vertical nystagmus, barking, generalized excitement, opisthotonus, tense abdominal musculature, tachypnea, nausea, emesis, urination, orbicularis muscle twitching, and death by respiratory paralysis and ventricular fibrillation. These actions must be centrally induced because intravenous strophanthin-I(, 31 pg/kg, had no effect on the animals while 77 &kg produced a bradycardia of only 9 minutes duration. No secondary effects were observed at either dose. Tryptamine-strophanthidin, 3.2 to 4.4 ,ug/ kg intraventricularly, produced bradycardia, decreased T-wave, increased Q-wave, and a depressed ST segment typical of digitalis. The secondary effects were similar to those seen with strophanthin-K. The 10.9 and 17.2 p g j k g intraventricular doses of tryptaminestrophanthidin corresponded in their cardiac and secondary effects with those observed with the 31.4 and 57.4 pg 'kg doses of strophanthin-K.
Results
Intravenous tryptamine-strophanthidin. 8.9 to 9.8 pg kg, produced little effect on the animals and doses of 20.1 to 26.8 pg kg produced a biphasic T-wave and a deep Q-wave or T-wave inversion with a late sagging ST segment and a bradycardia, rate 100 decreasing to 75. The cardiac effect had a duration of 10 minutes and none of the secondary effects seen after third ventricle injection were observed. Fig. 1 illustrates a typical electrocardiogram obtained with tryptamine-strophanthidin which is similar to that obtained with strophanthin-K. The effects observed after third ventricle injection must be related to the drugs because injection of the vehicles used produced no effect in the animals. Furthermore, anesthetization of the dogs with sodium pentobarbital reduced the cardiac rate and induced a regular sinus rhythm.
Disrussior?. From our results as well as those of Otto et d.( 1 ) , it appears that tryptamine-strophanthidin produced cardiac effects similar to those seen with the digitalis glycosides. The results obtained indicate that this new drug may be somewhat more potent than strophanthin-K. but further work must be done to firmly establish this point because Chen and Henderson( 2 ) have shown that the aglucone is more potent than tryptaminestrophanthidin. There can be no doubt that both compounds have central actions which affect the myocardium. The rapidity of onset after intraventricular injection does not allow time for sufficient drug to diffuse into the systemic circulation. The type of effects seen from the 2 routes of administration are diametrically opposite. Furthermore, barbiturate anesthesia abolished the arrhythmia (3) and intravenous hexamethonium or chlorpromazine abolished the arrhythrnia(4.5). Some of the effects seen after intracerebral injection might be attributed to irritation caused by the strophanthidin compounds. However, quinidine, also an irritant, did not cause the same cardiac effects, indicating at least that these effects are due to specific drug action and not irritation (4) .
The bradycardia and typical digitalis changes in the T-wave and the RS-T segment of the electrocardiogram observed with small doses of both strophanthidin derivatives indicate that, although such drugs can be shown to have direct effects on the myocardium, they may also affect this organ via the central nervous system. It is highly unlikely that the bradycardia seen after in t raven t ricular injection can be ascribed to a direct action on the carotid body because intravenous doses from 3-to 10-fold greater were required to produce slowing of the cardiac rate. This appears to be contrary to the report of Heymans et at?. (6) , but his experiments employed anesthesia which we have shown abolishes the central effects of these drugs. However, the short duration bradycardia occurring after intravenous injection could be mediated through an action on the carotid body. The larger intraventricular doses of the strophanthidin derivatives produce all the manifestations of cardiac glycoside toxicity indicating that this action too may have a central component.
Summary.
A comparison has been made of the effects produced by the intraventricular injection of strophanthin-K and tryptaminestrophanthidin. Both drugs produce bradycardia and typical digitalis changes in the Twave of the electrocardiogram a t low doses and manifestations of digitalis toxicity at higher doses. Some of the effects were not observed after much higher doses intravenously, thus indicating that the effects seen had their origin in the central nervous system. Anesthesia abolishes these actions of the strophanthidin derivatives, indicating that anesthesia should be avoided in the study of centrally mediated drug effects.
In a recently reported study(1) it was found that when protein was returned to the diet of potassium and protein-deficient rats there occurred a precipitous fall of the skeletal muscle potassium content. The animals continued to excrete potassium unabated despite a positive nitrogen balance. However, the negative potassium balance was found to be insufficient to account for the muscle potassium loss and it was suggested that with protein supplementation there might have been a redistribution of potassium within the body.
It seemed possible that the loss of potassium from the skeletal muscle of potassium and protein-deficient rats following realimentation with protein may be accompanied by an increase of the potassium content of other tissues. The present experiments were therefore undertaken to compare the electrolyte balance and the chemical composition of skeletal muscle, heart muscle, kidney and liver of potassium and protein-deficient rats upon supplementing the diet with (1) potassium and protein, ( 2 ) potassium, and ( 3 ) protein.
Young adult male rats of the tVistar strain, weighing between 260 and 290 g, were placed on a control diet(2)* for a period of at least 7 days. They were then divided into 2 groups: One group continued to receive the control diet for 5 weeks, while the second group was placed on a diet deficient in both potassium and protein for a period of 5 weeks. At the beginning of the 5th week, the rats were placed in individual metabolism cages for collections required for the balance studies. At the close of the 5-week period, the
Methods.
animals receiving the control diet and members of the group given the deficient diet were sacrificed to collect samples for the chemical analysis of the blood plasma and the tissues. Other members of the group given the deficient diet were placed for 6 days either on (1) the control diet, (2) a low-protein diet, or (3) a low-potassium diet. The experiment was then terminated and blood and tissues were collected for analysis. The nitrogen intake and the intakes of chloride, sodium and potassium were estimated on the basis of the amount of food consumed and the results of a chemical analysis of an aliquot of the ration. The excretions of the latter elements were determined by chemical analysis of aliquots of urine plus feces previously homogenized in a Waring blendor. The procedure for the collection of the tissues and the methods of their chemical analysis were essentially the same as previously described( 2,3) , except that plasma, tissues and diet sodium and potassium were determined with the Beckman Flame Spectrophotometer on nitric acid digests.
Results. Plasma composition. The data presented in Table I reveal that aside from a ~~ ~~ * Sheffield "De-Vitaminized" casein was used as the protein source; this ,brand has a lower potassium content than the casein employed earlier. For this study the vitamin supplements were considerably increased. The majority of vitamins were more than doulbled in quantity and p-aminobenzoic acid, folk alcid and vit. B,, were added to original supplement. The salt mixture as used in the earlier study was modified by increasing the calcium to maintain a Ca:P ratio of )between 2:l and 1:l whether the diet contained 24% casein or was protein-free. Further, the manganese content was increased, and, the silicon was omitted.
